Article

TaffiX® nasal powder spray forms an effective barrier against infectious new variants of SARS-CoV-2 (Alpha, Beta and Delta)

2021-08-04

Abstract excerpt

While vaccination efforts against SARS-CoV-2 around the world are ongoing, new highly infectious virus variants continue to evolve. The protection provided by the available vaccines against some of the new variants is weaker. Additional preventive measures will therefore be needed to protect the population until effective vaccinations are widely available. TaffiX ® is an anti-viral nasal powder spray comprised of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b22cd94f-98cd-55db-b15a-e7c2168c73a1
DOI: 10.21203/rs.3.rs-420365/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

TaffiX® nasal powder spray forms an effective barrier against infectious new variants of SARS-CoV-2 (Alpha, Beta and Delta)DOI 10.21203/rs.3.rs-420365/v2Read

A randomized, placebo-controlled trial of a nasal spray solution containing broadly potent neutralizing antibodies against SARS-CoV-2 variants in healthy volunteersSemantic proximity Read

Heparin Inhibits SARS-CoV-2 Replication in Human Nasal Epithelial CellsSemantic proximity Read

The real-world effectiveness of an intranasal spray A8G6 antibody cocktail in the post-exposure prophylaxis of COVID-19Semantic proximity Read

Inactivation of Human Coronavirus by Fathhome’s Dry Sanitizer Device: Rapid and Eco-friendly Ozone-based Disinfection of SARS-CoV-2Semantic proximity Read

COVID-19: Azelastine nasal spray Reduces Virus-load In Nasal swabs (CARVIN). Early intervention with azelastine nasal sprays reduces viral load in SARS-CoV-2 infected patients. First report on a double-blind placebo-controlled phase II clinical trial.Semantic proximity Read

Fighting the SARS CoV-2 (COVID-19) Pandemic with SoapSemantic proximity Read

Surface Inactivation of Highly Mutated SARS-CoV-2 Variants of Concern: Alpha, Delta, and OmicronSemantic proximity Read

Utility of nasal swabs for assessing mucosal immune responses towards SARS-CoV-2Semantic proximity Read

Neutral Electrolyzed Water (SES) for Nasopharyngeal and Oropharyngeal Rinses Prevented COVID-19 in Front-Line Health Professionals: A Randomized, Open-Label, Controlled Trial in a General Hospital in Mexico City.Semantic proximity Read

Virucidal activity of CPC-containing oral rinses against SARS-CoV-2 variants and are active in the presence of human salivaSemantic proximity Read

SARS-CoV-2 oral tablet vaccination induces neutralizing mucosal IgA in a phase 1 open label trialSemantic proximity Read

Development of a new Aerosol Barrier Mask for mitigation of spread of SARS-CoV-2 and other infectious pathogensSemantic proximity Read